Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Emergent BioSolutions (NYSE: EBS) announced that Joe Papa, president and CEO, will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) announced that Joe Papa, president and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 5:15 PM PST. An audio link to the session will be available and kept live for up to 30 days. The company said its presentation slides will be posted on the Investors section of the Emergent website at the time of the presentation.
Details
News Market Reaction – EBS
On Jan 7, the day this news came out, EBS closed 5.70% above the previous close.
Data tracked by StockTitan Argus for the Jan 7 session.
Key Figures
- Conference date
- January 14, 2026
- J.P. Morgan Healthcare Conference presentation date
- Presentation time
- 5:15 PM PST
- Scheduled time of conference presentation
- Audio availability
- 30 days
- Length of time conference audio will remain accessible
- Conference edition
- 44th Annual
- Edition of the J.P. Morgan Healthcare Conference
Historical Context
-
FDA cleared Winnipeg facility for raxibacumab drug product manufacturing and testing.
-
Marked 10-year NARCAN Nasal Spray approval anniversary and highlighted naloxone access efforts.
-
Announced retirement of long-serving director Louis W. Sullivan from the board.
-
Q3 2025 beat revenue guidance and raised full-year outlook with solid margins.
-
Released survey on biological threat concerns and highlighted biodefense capabilities.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST.
The audio link for Emergent’s session may be accessed here and will be live for up to 30 days.
The Company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.